Skip to main content
Tatsu Shimoyama on Muck Rack

Tatsu Shimoyama

As seen in: Nature, Annals of Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tatsu

Contact Tatsu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy | Bone Marrow Transplantation

|
By Yu Yagi, Yusuke Kanemasa, Hideki Goto, Masahide Yamamoto, Maki Hagihara, Toshio Kitawaki, Tatsu Shimoyama, Ryo Hanajiri, Shinichi Makita, Go Yamamoto, Masatoshi Sakurai, Nobuharu Fujii, Takahide Ara, Yasuhiro Nakashima, Akiyo Yoshida, Hideyuki Nakazawa, Emiko Sakaida, Nobuhiro Kanemura, Keisuke Kataoka, Yoshiko Atsuta, Koji Kato, Kotaro Miyao, Haryoon Kim
| Nature Verified
For patients with relapsed/refractory large B-cell lymphoma (LBCL) undergoing chimeric antigen receptor (CAR) T-cell therapy, pre-infusion disease burden and response status are recognized determinants of prognosis [1, 2]. Bridging therapy (BT) is designed to control the disease burden after leukapheresis and before the initiation of lymphodepleting chemotherapy.
Open in Who Shared Issue with article?

O1-14-3Study of Pneumocystis Pneumonia of Trimethoprim/Sulfamethoxazole in NHL patients receiving R-CHOP regimen

|
By Yuta Ishiyama, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura
| Annals of Oncology Verified
O1-14-3Study of Pneumocystis Pneumonia of Trimethoprim/Sulfamethoxazole in NHL patients receiving R-CHOP regimen Objective: There are few evidence of administering Trimethoprim/Sulfamethoxazole(TMP/SMX) to privent Pneumocystis Pneumonia(PcP) in NHL patients receiving R-CHOP regimen. We did review to find out the relevance of PcP …
Open in Who Shared Issue with article?

O2-12-2Outcome Analysis of DLBCL in HIV-infected and non-HIV-infected patients

|
By Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura
| Annals of Oncology Verified
O2-12-2Outcome Analysis of DLBCL in HIV-infected and non-HIV-infected patients Yusuke Kanemasa1, Tatsu Shimoyama1, Yuki Sasaki2, Miho Tamura1, Takeshi Sawada1, Yasushi Omuro1, Ryoko Sekiya3, Naoki Yanagisawa3, Akifumi Imamura3, Tsunekazu Hishima4 and Yoshiharu Maeda1 1Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital 2Department of Clinical Research Support, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital...
Open in Who Shared Issue with article?
See all 3 articles